Systemic administration of nitroalkenes such as nitro-oleic acid (NO2-OA) in an animal model of hypertension results in inhibition of ANG II type 1 receptor (AT-1)-dependent vasoconstriction and diminution of overall ANG II-induced damage [20]. This evidence concerns the gene AGT and Hypertension.